Robert Sassoon
@robert_sassoon
Followers
5
Following
33
Media
0
Statuses
146
Joined February 2022
RT @WTR_Research: Read Robert Sassoon's recap from his recent fireside chat with @AinosInc (NASDAQ: AIMD) Director of Corporate Development….
0
4
0
RT @WTR_Research: Vivos (NASDAQ: VVOS) is pivoting its business model following the June 2025 SCN acquisition, shifting from a provider-foc….
0
4
0
RT @WTR_Research: Read @robert_sassoon's recap following his recent podcast with Dr. Marvin S. Hausman MD, Co-Founder & CSO of Ludwig Enter….
0
3
0
RT @WTR_Research: In this episode of WTR Healthcare Happenings, Dr. Marvin Hausman, Co-Founder & CSO of Ludwig Enterprises Inc. (OTC: LUDG)….
0
3
0
RT @WTR_Research: Enlivex Therapeutics (Nasdaq: ENLV) announced positive topline Phase I/II data from its Allocetra™ trial in patients with….
0
3
0
RT @WTR_Research: Ainos, Inc. (NASDAQ: AIMD) is now being covered under our Technology platform, reflecting its pivot from biotech roots to….
0
141
0
RT @WTR_Research: Catch @robert_sassoon's recap from his recent podcast with Brent Lucas, CEO of @EnvoyMedical (NASDAQ: COCH), an innovativ….
0
2
0
RT @WTR_Research: New WTR Healthcare Happenings Podcast!. @EnvoyMedical CEO Brent Lucas joins Tim Gerdeman & @robert_sassoon to discuss how….
0
4
0
RT @WTR_Research: Cybin Inc secures EU green light for EMBRACE Phase 3 trial ✅ — advancing its CYB003 program for major depressive disorder….
0
8
0
RT @WTR_Research: Please join Robert Sassoon for a conversation with @AinosInc (NASDAQ: AIMD) Director of Corporate Development Jack Lu on….
0
4
0
RT @WTR_Research: New Coverage Alert: Tian Ruixiang Holdings (NASDAQ: TIRX). WTR has initiated coverage on TIRX, a company blending AI-powe….
0
4
0
RT @WTR_Research: Ainos' VELDONA Advances with Taiwan FDA Approval. @AinosInc (NASDAQ: AIMD) announces Taiwan FDA approval to start a key c….
0
7
0
RT @WTR_Research: CYBN: CYB003 vs. GH001. New Data Alert: GH Research (NASDAQ: GHRS) released final 6-month data from its Phase 2b OLE stud….
0
7
0
RT @WTR_Research: New Episode Alert: WTR Small-Cap Spotlight. WTR's Tim Gerdeman & @robert_sassoon joined by Jack Lu, Director of Corporate….
0
8
0
RT @WTR_Research: Read @robert_sassoon's recap and transcript from his recent fireside chat with @AinosInc (NASDAQ: AIMD) Director of Corpo….
0
81
0
RT @lisata_tx: Lisata's leadership team recently discussed its novel tumor-penetrating therapy, certepetide, and the preliminary Ph 2b resu….
pod.link
Listen to WTR Small-Cap Spotlight wherever you get your podcasts!
0
3
0
RT @WTR_Research: Check out Robert Sassoon's recap following his latest podcast with Lisata Therapeutics, Inc. (NASDAQ:LSTA) CEO David J. M….
0
3
0
RT @WTR_Research: On the latest WTR Healthcare Spotlight podcast, Tim Gerdeman and @robert_sassoon were joined by @lisata_tx (NASDAQ: LSTA)….
0
2
0
RT @WTR_Research: Cybin Inc expands its Phase 3 program for CYB003 with UK regulatory approval. 🔹 UK MHRA approves EMBRACE, a larger, mult….
0
7
0
RT @WTR_Research: Check out @robert_sassoon's recap from his latest podcast with @insidepharma, CEO of @CybinInc (NYSE:CYBN) dsicussing com….
0
5
0